Equity Overview
Price & Market Data
Price: $2.40
Daily Change: -$0.03 / 1.25%
Range: $2.37 - $2.49
Market Cap: $83,244,240
Volume: 165,235
Performance Metrics
1 Week: 13.74%
1 Month: -16.08%
3 Months: -20.00%
6 Months: -51.81%
1 Year: -45.58%
YTD: -31.82%
Company Details
Employees: 25
Sector: Health technology
Industry: Pharmaceuticals: major
Country: Canada
Details
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc., which is headquartered in Vancouver, Canada.